FUJIFILM CORP. TO MANUFACTURE NOVAVAX INC.’S COVID-19 VACCINE CANDIDATE

• Fujifilm Corp. to manufacture Novavax Inc.’s COVID-19 vaccine candidate.
• Both companies agreed to manufacture bulk drug substance for the vaccine candidate.
• Novavax has been developing NVX-CoV2373, a vaccine for COVID-19.
• A pivotal phase 3 clinical trial of up to 30,000 subjects is under the way.

On Friday, Fujifilm Corp mentioned that its biotechnology subsidiary and U.S. vaccin....